Aliviar

Data Snapshot: Jun 11, 2024
Aliviar Cannabis Brand Logo
<$50K

May-2024

Sales

Strong Growth

Trend

6-Month

6

Product Count

SKUs

Aliviar

Overview

Aliviar is a medical cannabis brand, developed by MedPharm, renowned for its CBD-rich formulation that offers a 20:1 CBD to THC ratio, which primarily serves patients seeking to alleviate chemotherapy-induced nausea and other ailments without the psychoactive effects of THC. As part of the Bud & Mary's family of lifestyle and medical cannabis brands, Aliviar is a reputable name in the cannabis industry, prioritizing research and product development. Notably, this brand is often sought after in Colorado for delivering natural, rapid-action solutions via its conscientiously developed products.
Markets

Aliviar Locations

Product Trends

Aliviar Categories

Aliviar Sales

Market Insights Snapshot

Aliviar Historical Sales by Category

Aliviar has shown notable performance in the Colorado market, particularly within the Tincture & Sublingual category. Over the past few months, Aliviar has consistently maintained a strong presence, moving from a rank of 4 in February 2024 to an impressive rank of 2 by May 2024. This upward trend is indicative of increased consumer preference and possibly effective marketing strategies. Sales figures corroborate this improvement, with a steady increase from $27,497 in February to $34,497 in May. However, in the Topical category, Aliviar's presence was absent from the top 30 rankings until May 2024, where it debuted at rank 10. This late entry could be seen as a positive sign of emerging growth in a new category.

While Aliviar's performance in the Tincture & Sublingual category in Colorado has been robust, the absence of rankings in the Topical category for the months of February through April suggests room for improvement. The brand's appearance in the top 10 in May might indicate initial success in a new strategic focus or product launch. This movement should be closely monitored to determine if it represents a sustainable trend or a temporary spike. In summary, Aliviar's performance in Colorado underscores its strength in the Tincture & Sublingual category while highlighting potential growth opportunities in the Topical segment.

May-2024 Rank
Tincture & Sublingual
Topical
2
10
Aliviar

Competitive Landscape

In the competitive landscape of the Colorado Tincture & Sublingual category, Aliviar has demonstrated notable resilience and growth. Over the past four months, Aliviar's rank has fluctuated, showing a significant improvement from 4th place in February 2024 to 2nd place by May 2024. This upward trend highlights Aliviar's increasing market presence and consumer preference. In contrast, ioVia has maintained a stronghold on the top position for most months, except for a brief dip to 2nd place in April 2024. Meanwhile, Escape Artists experienced a decline, dropping from 2nd place in February and March to 4th place in May. My Brother's Flower has shown consistent performance, maintaining a steady 3rd place in most months. Aliviar's ability to climb the ranks amidst such strong competition indicates a successful strategy and growing consumer loyalty, positioning it as a formidable player in the market.

Aliviar market ranking for CO Tincture & Sublingual

Aliviar

Notable Products

In May-2024, the top-performing product for Aliviar was the CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC) in the Tincture & Sublingual category, maintaining its number one rank with sales of 1014 units. The CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml) also held steady in second place. The CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz) saw a significant rise from fifth to third place, indicating a notable increase in popularity. The CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz) dropped one position to fourth, while the CBD/THC 2:1 Sport Cream (420mg CBD, 210mg THC,2oz) fell to fifth. Overall, the rankings show some shifts in the Topical category, highlighting changing consumer preferences.

Product Rank
Category
Feb-2024
Mar-2024
Apr-2024
May-2024
CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC)
Tincture & Sublingual
1
1
1
1
CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml)
Tincture & Sublingual
2
2
2
2
CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz)
Topical
5
5
5
3
CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz)
Topical
3
3
3
4
CBD/THC 2:1 Sport Cream (420mg CBD, 210mg THC,2oz)
Topical
4
4
4
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.
Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data